Zydus Cadila receives USFDA approval for Acylovir
Zydus Cadila has received final USFDA approval to market Acylovir drug for injection USP in strengths of 500 mg/vial and 1000 mg/vial. The drug is […]
Zydus Cadila has received final USFDA approval to market Acylovir drug for injection USP in strengths of 500 mg/vial and 1000 mg/vial. The drug is […]
Natco Pharma Ltd has got the final USFDA approval for the generic version of Vidaza (Azacitidine for injection, 100 mg per vial), single-dose vial. Natco […]
Zydus Cadila has received final USFDA approval to market oxybutynin chloride tablets in USA. The drug is used to treat overactive bladder and urinary incontinence […]
Glenmark Pharmaceuticals has received final USFDA approval for its generic version of anti-inflammatory drug Indomethacin tablets. The drug is the generic equivalent of Indocin SR […]
Lupin has received final USFDA approval to market a generic version of Novartis’ inhalation product Tobi, which is used to treat cystic fibrosis, in the […]
Unichem Laboratories has received final USFDA approval for Piroxicam capsules, used in the treatment of osteoarthritis and rheumatoid arthritis, in the US market. The approved […]
Alembic Pharmaceuticals has received final USFDA approval for Fenofibric acid delayed-release capsules used for lowering high cholesterol and increasing good cholesterol. The approved product is […]
Alembic Pharmaceuticals has received final USFDA approval for two anti-hypertension tablets – olmesartan medoxomil tablets, 5 mg, 20 mg, and 40 mg and olmesartan medoxomil […]
Wockhardt has received USFDA approval to market generic version of Wyeth’s Zosyn, used for treating bacterial infections, in the American market. Wockhardt Bio AG had […]
Glenmark Pharmaceuticals has received USFDA approval for Clobetasol Propionate Ointment used for treatment of various skin conditions. The approved product is a generic version of […]
Copyright © 2024 | WordPress Theme by MH Themes